EO2401
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EO2401, covering 2026-01-30 to 2026-01-30. Get the full timeline:
Most recent: Clinical Trial Update: A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma [Phase 1, Phase 2]